Cannabis Report in text over top a photo of cannabis leaves
(Source: File)

A Vancouver-based cannabis company is now able to capitalize on the growing demand of its products as the only legal company that has been granted authorization to domestically produce and sell CBD products in Mexico. Its stock is up nearly 60 per cent in the past year.

Click here for the full story.

CBD oil on marijuana leaves
(Source: Adobe Stock)

Weekly Update – Top Cannabis News Stories

1 | Top Story: Tilray (TSX:TLRY) launches medical cannabis study for patients over 50.

2 | Cannabix (CSE:BLO) reports positive results from early testing of its marijuana breathalyzer by Omega Laboratories.

3 |  Canada’s largest private-sector cannabis retailer acquired the entire indebtedness of Delta 9 Cannabis Inc. (TSX:DN) held by Connect First and Servus Credit Union.

Top Cannabis Stocks July 5 to July 11, 2024

1. T.TLRY | 10,657 views | .Tilray Brands Inc.
2. T.LABS | 2,875 views | Medipharm Labs Corp.
3. C.CURA | 2,765 views | Curaleaf Holdings Inc.
4. T.WEED | 2,575 views | Canopy Growth Corp.
5. TSX:DN | 1,937 views | Delta 9 Cannabis Inc.
6. TSXV:LFST | 1,522 views | Lifeist Wellness Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online
Air Canada airliner

Air Canada negotiates new labour deal with pilots, avoids shutdown

Air Canada (TSX:AC) and the union representing thousands of its pilots negotiated a new labour deal and averted a nationwide shutdown.
Tudor Gold 2020 drilling at Treaty Creek.

Tudor Gold to advance Treaty Creek Project with Fuse Advisors

Tudor Gold (TSXV:TUD) enters into an agreement with Fuse Advisors to advance the Treaty Creek Project in British Columbia's Golden Triangle.
U.S. Food and Drug website in browser with logo

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.
King's Cross station in London

AtkinsRéalis boosts long-term revenue with U.K. rail contract

AtkinsRéalis Group (TSX:ATRL) will modernize the U.K.'s rail signalling infrastructure over the next decade.